未登录 Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study 氯沙坦与阿替洛尔对高血压和左心室肥厚患者血脂的影响: 氯沙坦干预降低高血压研究的终点 Olsen, Michael Hecht; Wachtell, Kristian; Beevers, Gareth; Dahlof, Bjorn; de Simone, Giovanni; Devereux, Richard B.; de Faire, Ulf; Fyhrquist, Frej; Ibsen, Hans; Kjeldsen, Sverre E.; Lederballe-Pedersen, Ole; Lindholm, Lars H.; Lyle, Paulette A.; Nieminen, Markku S.; Omvik, Per; Oparil, Suzanne; Wedel, Hans 分享 收藏
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy Parving, Hans-Henrik; de Zeeuw, Dick; Cooper, Mark E.; Remuzzi, Giuseppe; Liu, Nancy; Lunceford, Jared; Shahinfar, Shahnaz; Wong, Peggy H.; Lyle, Paulette A.; Rossing, Peter; Brenner, Barry M. 分享 收藏
Effects of Losartan in women with hypertension and left ventricular hypertrophy results from the Losartan Intervention For Endpoint Reduction in hypertension study 氯沙坦对高血压和左心室肥厚女性的影响来自氯沙坦干预降低高血压研究终点的结果 Os, Ingrid; Franco, Veronica; Kjeldsen, Sverre E.; Manhem, Karin; Devereux, Richard B.; Gerdts, Eva; Hille, Darcy A.; Lyle, Paulette A.; Okin, Peter M.; Dahlof, Bjorn; Oparil, Suzanne 分享 收藏
分享 收藏
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study Tershakovec, Andrew M.; Keane, William F.; Zhang, Zhongxin; Lyle, Paulette A.; Appel, Gerald B.; McGill, Janet B.; Parving, Hans-Henrik; Cooper, Mark E.; Shahinfar, Shahnaz; Brenner, Barry M. 分享 收藏
分享 收藏
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy:: the LIFE study Fossum, E.; Gleim, G. W.; Kjeldsen, S. E.; Kizer, J. R.; Julius, S.; Devereux, R. B.; Brady, W. E.; Hille, D. A.; Lyle, P. A.; Dahlof, B. 分享 收藏
A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily Losartan 100mg/hydrochlorothiazide 12.5 mg compared with Losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension Gleim, Gilbert W.; Rubino, Joseph; Zhang, Hongyan; Shahinfar, Shahnaz; Soffer, Beth A.; Lyle, Paulette A.; Littlejohn, Thomas W., III; Feig, Peter U. 分享 收藏
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL study Keane, William F.; Zhang, Zhongxin; Lyle, Paulette A.; Cooper, Mark E.; de Zeeuw, Dick; Grunfeld, Jean-Pierre; Lash, James P.; McGill, Janet B.; Mitch, William E.; Remuzzi, Giuseppe; Shahinfar, Shahnaz; Snapinn, Steven M.; Toto, Robert; Brenner, Barry M. 分享 收藏
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy?: The LIFE study Ibsen, H; Olsen, MH; Wachtell, K; Borch-Johnsen, K; Lindholm, LH; Mogensen, CE; Dahlöf, B; Snapinn, SM; Wan, Y; Lyle, PA 分享 收藏
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy 高血压和左心室肥厚患者的脉压和氯沙坦或阿替洛尔的影响 Fyhrquist, F; Dahlöf, B; Devereux, RB; Kjeldsen, SE; Julius, S; Beevers, G; de Faire, U; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Hille, DA; Lyle, PA; Edelman, JM; Snapinn, SM; Wedel, H 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
